Democrats say Trump increased investments in drugmakers that were given Medicare exemptions
The report from congressional Democrats found that Trump's pharmaceutical stock holdings grew from a maximum reported value of $1.7 million in 2024 to as much as $56.2 million at the end of 2025.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.pbs.org — the content belongs to PBS NewsHour.